Riskpilot← Back to searchSign inGet full accessHober Medical AB
ABActiveOrg 5566014063Linnégatan 9-11General medical practice activities · NACE 8621Est. 20000 employees
Revenue 2024
SEK 0
EBITDA margin
—
+12% vs 2023
Equity ratio
39.9%
Financial strength
Net profit 2024
SEK 2,2M
+21440% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -45K | +12% |
| Net profit | SEK 2,2M | +21440% |
| Total assets | SEK 15,7M | -24% |
| Equity | SEK 6,3M | +52% |
| Employees | 0 | — |
Legal name
Hober Medical AB
Org number
5566014063
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 december 2000
Share capital
SEK 500 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Hober, Dag Magnus
Company purpose
Bolaget skall självt samt genom hel- och delägda bolag bedriva verksamhet inom sjuk- och hälsovård och därmed förenlig verksamhet.
Address
Linnégatan 9-11
Phone
+4684114340
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −36 | −37 | −37 | −51 | −45 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −36 | −37 | −37 | −51 | −45 |
| Net financials | 5 002 | 4 997 | 3 989 | 17 | 2 051 |
| Profit before tax | 5 087 | 4 961 | 3 951 | 15 | 2 179 |
| Tax | −20 | −0 | −0 | −5 | −25 |
| Net profit | 5 067 | 4 961 | 3 951 | 10 | 2 154 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 251 | 25 214 | 20 677 | 20 698 | 15 744 |
| Equity | 9 211 | 9 172 | 8 123 | 4 133 | 6 287 |
| Long-term debt | 15 688 | 15 688 | 12 220 | 12 265 | 9 281 |
| Short-term debt | 1 042 | 44 | 24 | 4 038 | 88 |
| Total debt | 16 730 | 15 732 | 12 244 | 16 303 | 9 369 |
EBITDA margin
-4500000.0%
This company
15.8%
Market median
-28481113% vs market
20202024
Equity ratio
39.9%
This company
38.2%
Market median
+4% vs market
20202024
Return on equity
34.3%
This company
18.4%
Market median
+86% vs market
20202024
Net profit margin
215400000.0%
This company
8.1%
Market median
+2659259159% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HH Chief Auditor | Chief Auditor | 2022 |
DM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
STUDSTON LTD
Hober Medical AB Board members of Hober Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hök Hans Olov Erik Forsberg | Chief Auditor | 0 companies |
| Dag Magnus Hober | Chief Executive Officer | 0 companies |
| Sophia Elisabeth Hober | Board of Directors | 0 companies |
| Johan Arthur Gustavsson | Chairman | 0 companies |